NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia [Yahoo! Finance]
NeoGenomics, Inc. (NEO)
Last neogenomics, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.neogenomics.com
Company Research
Source: Yahoo! Finance
FT. MYERS, Fla., October 08, 2024 BUSINESS WIRE NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, announced today the launch of AML Express, a next-generation sequencing (NGS) assay designed to provide rapid, comprehensive genetic profiling for patients with acute myeloid leukemia (AML). "AML Express enhances our hematologic portfolio by addressing the clinical need for faster testing that informs critical treatment decisions," said Chris Smith, CEO of NeoGenomics. "This new test offers physicians a more efficient solution that delivers patient-specific insights to guide precise treatment strategies." AML accounts for about 1 out of 3 leukemias in adults. It is an aggressive disease that often develops and progresses rapidly over a few weeks, making access to timely and accurate diagnostic and prognostic information critical for patient care. With a turnaround time of just three to four days, AML Express delivers a time- and cost-effective alternative
Show less
Read more
Impact Snapshot
Event Time:
NEO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NEO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NEO alerts
High impacting NeoGenomics, Inc. news events
Weekly update
A roundup of the hottest topics
NEO
News
- NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment [Yahoo! Finance]Yahoo! Finance
- NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized TreatmentBusiness Wire
- Felicia Williams Joins NeoGenomics Board of Directors [Yahoo! Finance]Yahoo! Finance
- Felicia Williams Joins NeoGenomics Board of DirectorsBusiness Wire
- NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare ConferenceBusiness Wire
NEO
Earnings
- 11/5/24 - Beat
NEO
Sec Filings
- 11/19/24 - Form 4
- 11/15/24 - Form 144
- 11/14/24 - Form SC
- NEO's page on the SEC website